Table 1.

Distribution of clinical features of endometrial cancers by race and ethnicity, SEER, 2000–2011

NHWNHBHispanicAsian
N (%)N (%)N (%)N (%)
Total90,62110,36511,3868,141
Age at diagnosis
 <509,882 (11%)1,196 (12%)2,974 (26%)2,021 (25%)
 50–5924,592 (27%)2,338 (23%)3,284 (29%)2,780 (34%)
 60–6926,380 (29%)3,584 (35%)2,825 (25%)1,924 (24%)
 70–7918,125 (20%)2,281 (22%)1,648 (14%)1,009 (12%)
 80+11,642 (13%)957 (9%)655 (6%)407 (5%)
Histology
 Endometrioid73,531 (81%)6,414 (62%)9,009 (79%)6,515 (80%)
 Serous4,230 (5%)1,222 (12%)613 (5%)409 (5%)
 Mixed4,182 (5%)522 (5%)524 (5%)403 (5%)
 MMMT4,019 (4%)1,307 (13%)554 (5%)361 (4%)
 Clear cell1,103 (1%)268 (3%)151 (1%)125 (2%)
 Other3,556 (4%)623 (6%)535 (5%)328 (4%)
Grade
 Low (well to moderately differentiated)58,578 (65%)4,458 (43%)7,390 (65%)5,307 (65%)
 High (poor to undifferentiated)19,192 (21%)3,776 (36%)2,422 (21%)1,914 (24%)
 Unknown12,851 (14%)2,122 (20%)1,574 (14%)920 (11%)
SEER summary stage
 Local63,316 (70%)5,504 (53%)7,512 (66%)5,490 (67%)
 Regional16,173 (18%)2,453 (24%)2,189 (19%)1,584 (19%)
 Distant7,458 (8%)1,698 (16%)1,175 (10%)820 (10%)
 Unknown3,674 (4%)701 (7%)510 (4%)247 (3%)